AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ligand Pharmaceuticals Incorporated

$322.75 +$132.64 (+69.77%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$317.33
Day Range
$315.98$324.12
Year Range
$175.89$326.63
Market Cap
6.43B
AVG Volume
291.3K
Trailing/Forward PE
124.61/26.04
PEG ratio
4.87
Dividend Yield
-
Next Earnings Date
2027-02-25
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
LGND Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q3253.83M
26 Q2290.54M
26 Q1274.48M
25 Q4268.09M
25 Q3251.23M
25 Q2187.58M
25 Q1181.49M
24 Q4167.13M
24 Q3152.42M
24 Q2133.48M
Net Income (USD) · TTM
-200M-100M0100M200M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
LGND Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q351.46M
26 Q2197.22M
26 Q1153.56M
25 Q4124.45M
25 Q348.58M
25 Q2-75.86M
25 Q1-132.62M
24 Q4-4.03M
24 Q345.24M
24 Q242.14M
Operating Income (USD) · TTM
-100M-50M050M100M150M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
LGND Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q330.24M
26 Q2100.93M
26 Q1100.78M
25 Q447.2M
25 Q317.52M
25 Q2-34.27M
25 Q1-61.81M
24 Q4-22.61M
24 Q3-16.33M
24 Q2-16.39M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: LGND

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 25 Feb 2027.

Ligand Pharmaceuticals Incorporated
LGND
Stockpicker

Video analysis: LGND

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LGND

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.